Has Christopher Haley, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,027 in general payments to Christopher Haley, MD across 49 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Haley, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Haley, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Haley, MD

Dermatology · Temple, TXNPI 1013368851

Payments from drug & device makers

$5,027in general payments, 2019–2025

Across 49 payments — averaging $102.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$2K
Novartis Pharma AG$1K
AbbVie$602
Janssen Scientific Affairs, LLC$253
Sun Pharmaceutical Industries Inc.$217
Galderma Laboratories, L.p.$196
plus $582 from 6 others

What the payments were for

Travel & lodging$2,51950%
Food & beverage$2,50850%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	11	$2,163
Novartis Pharma AG	6	$1,013
AbbVie	13	$602
Janssen Scientific Affairs, LLC	2	$253
Sun Pharmaceutical Industries Inc.	4	$217
Galderma Laboratories, L.p.	2	$196
Sanofi	3	$144
Johnson & Johnson	2	$132
E.r. Squibb & Sons, L.L.C.	1	$116
UCB, Inc.	2	$94
Almirall LLC	1	$58
LEO Pharma Inc.	2	$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,027 in reported general payments places this provider in the 50th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Medicare billing

Part B allowed, 2024

$185,348

Medicare patients

535

Services billed

2,811

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Skyrizi PenRisankizumab-Rzaa	11	$243,573
Dupixent PenDupilumab	37	$135,277
Clobetasol Propionate	103	$4,203
Fluorouracil	54	$3,248
Fluocinonide	64	$2,501
Ketoconazole	166	$2,255
Hydrocortisone	96	$1,305
Doxycycline Monohydrate	61	$1,277
Pentoxifylline	18	$1,253
Triamcinolone Acetonide	86	$1,167
Clindamycin Phosphate	38	$960
Metronidazole	25	$828
ValacyclovirValacyclovir Hcl	21	$695
Tretinoin	12	$583
Fluocinolone AcetonideFluocinolone/Shower Cap	11	$510

Paid to pharmacies, not to this prescriber.

Other dermatology in Temple

Stephen TyringWebster$14.1M
Edward LainAustin$12M
Mark LeeSan Antonio$10.9M
John BrowningSan Antonio$10.7M
Craig TellerBellaire$7.7M
Patricia LeeWebster$7.2M
Jennifer CatherDallas$4.9M
Michael MigdenHouston$3.7M
Martin MenterDallas$3.7M
Janet DuboisAustin$3.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →